Oncobox was founded by Andrew Garazha, Anton Buzdin.

Who are Oncobox's investors?

Oncobox's investors include Y Combinator.

Where is Oncobox headquartered?

Oncobox is headquartered in Walnut, US.

Oncobox

Walnut, US · 11 employees · 1 known investors

Find your way into Oncobox

422 people in our graph share verified history with the Oncobox team — schools, employers, funds. One of them is your warm intro.

Akshat Goenkaunlockedknows Andrew Garazha · together at Y Combinator (overlapped)

×9knows the team · via Y Combinator

knows the team · via Caltech

knows the team · via Lomonosov Moscow State University (MSU)

Oncobox provides genetic profiling of tumor samples to help oncologists select the most likely effective drug from existing targeted cancer therapies for individual patients with advanced cancer. The analysis examines tumor DNA, RNA, and molecular pathways to identify the most relevant drug targets and generates a clinical report recommending which treatments are most likely to work.

Digital Health Healthtech Medical Devices Drug discovery OncologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S17)

Andrew Garazha inCo-founder · Chief Executive OfficerAndrew Garazha is founder and CEO of Oncobox, which performs genetic profiling of tumor samples to identify targeted cancer therapies most likely to be effective for individual patients. He has a background in bioinformatics and precision medicine.

Anton Buzdin inCo-founder · CSOAnton Buzdin is founder and Chief Scientific Officer of Oncobox, a cancer diagnostics company that analyzes tumor genetics and molecular pathways to guide oncologists in selecting targeted therapies for advanced cancer patients. He has background in genetics, bioinformatics, and molecular medicine.

Investors · 1

Y CombinatorSan Francisco · $500K

Competitors · 6

by search overlap

Oncohealth10 shared keywordsOncoHealth develops software and services to help health plans, employers, and oncologists manage cancer care and reduce treatment complexity. The platform combines oncology management tools with nursing, mental health, nutrition, and navigation services for patients and health systems.

OncoLens6 shared keywordsOncoLens provides a platform that connects cancer care teams and enables multidisciplinary cancer management, helping cancer centers coordinate care, manage tumor boards, and access clinical trials and biomarker testing.

Onco6 shared keywordsOnco provides cancer patients in India with access to expert oncologists, quality treatment centers, discounted cancer medicines, diagnostic tests, and support throughout their treatment journey. The platform connects patients with specialists, offers curated treatment packages, and provides survivor mentorship and remote answers to cancer-related queries.

OneOncology6 shared keywordsOneOncology invests in and partners with community oncology practices to deliver cancer care, helping them grow, diversify across specialties, and apply data and technology to improve performance. It operates a network of oncology and urology practices across the United States.

Onc4 shared keywordsOnc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making. Its products serve pharma companies with Phase IB/II clinical trial decisions and predict immunotherapy response and outcomes for metastatic lung cancer patients.

Oncosenx3 shared keywordsOncoSenX is a late-stage pre-clinical cancer therapeutics company developing treatments that target solid tumors based on transcriptional activity. Its system pairs a patented Proteo-Lipid Vehicle (PLV) delivery agent with plasmid DNA payloads that induce apoptosis in cancer cells while sparing adjacent cells.

Companies competing with Oncobox for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Oncobox do?: Oncobox provides genetic profiling of tumor samples to help oncologists select the most likely effective drug from existing targeted cancer therapies for individual patients with advanced cancer. The analysis examines tumor DNA, RNA, and molecular pathways to identify the most relevant drug targets and generates a clinical report recommending which treatments are most likely to work.
Who founded Oncobox?: Oncobox was founded by Andrew Garazha, Anton Buzdin.
Who are Oncobox's investors?: Oncobox's investors include Y Combinator.
Where is Oncobox headquartered?: Oncobox is headquartered in Walnut, US.